During the Minamata Convention on Mercury meeting in Geneva, Health Secretary Robert F. Kennedy Jr. urged all countries to eliminate mercury from vaccines, following the United States' lead. He highlighted the inconsistency in public health standards, questioning why mercury is deemed hazardous in many products but accepted in vaccines.
• Advocacy for Change: Kennedy emphasized that thimerosal, a mercury-based preservative in vaccines, should not be allowed, especially considering its potential dangers to vulnerable populations like pregnant women and babies.
• Safety Concerns: He stated that thimerosal has not been properly tested for safety in humans, citing numerous studies that label it as a neurotoxin, carcinogen, and endocrine disruptor. Kennedy pointed out the legal requirements that treat thimerosal as hazardous and the lack of evidence proving its safety in vaccines.
• Historical Context: The U. S. began removing thimerosal from vaccines in 1999 due to studies indicating risks to children. In July 2023, Kennedy supported a recommendation to eliminate thimerosal from influenza vaccines.
• Global Call to Action: Kennedy called on health authorities worldwide to adopt the U. S. decision and remove mercury from vaccines. He stated that manufacturers confirmed they could produce vaccines without mercury without supply disruptions.
• Contradictory Views on Safety: The American Academy of Pediatrics (AAP) defended thimerosal, asserting that extensive research has shown it to be safe in vaccines. They emphasized that removing thimerosal could cause unnecessary fear regarding vaccination.
• Research Findings: A study indicated that thimerosal exposure in rats resulted in brain damage, while other studies have linked it to kidney toxicity. However, the CDC recently reported that side effects from thimerosal-containing vaccines are minor and not associated with autism.
The debate over thimerosal in vaccines centers on balancing safety and public confidence in vaccine programs. As calls to remove mercury grow, differing opinions highlight the need for continuous assessment of vaccine components.
No comments:
Post a Comment